New trends in the medical treatment of carcinoma of the stomach

Author summarizes literature data concerning the medical treatment of gastric carcinoma with cytostatic chemotherapy. From the review of the available clinical results, as well as from the personal experience with the recently introduced FAM scheme [5-.fluorouracil + adriamycin + mitomycin C] producing 44% objective response rate [complete + partial >/= 50% tumor reduction], it can be concluded that polychemotherapy-especially the more recent adriamycin containing combinations is an effective and applicable tool for palliation of advanced and metastatic gastric cancer